Sign in
CompletedNo phase

The Remote Monitoring of Gout Feasibility Study

Key facts

Who runs it
Diakonhjemmet Hospital
Where
Norway1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
21 people enrolled
Started
27 Feb 2024
Ended
11 Oct 2024
Type of study
Interventional
Treatments tested
  • "Urika", a self-management application for patients with gout
Record updated
11 December 2024

Who can take part

Age
19 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Male or non-pregnant, non-nursing female >18 years of age at screening
  • Patients with a clinical diagnosis of gout
  • Patients who fulfil the American College of Rheumatology (ACR)/EULAR classification criteria
  • Serum urate level >360 μmol/L at inclusion
  • Having a smartphone/tablet

Who cannot take part

  • Contraindication for urate lowering therapy
  • Major co-morbidities (e.g., malignancies, severe cardiovascular disease, severe diabetes mellitus, severe respiratory diseases)
  • Psychiatric or mental disorders, alcohol abuse or other substance abuse, language barriers or other factors which makes adherence to the study protocol difficult
  • Unstable medical conditions (e.g,, uncontrollable hypertension, impaired liver function); known stage 3b or higher chronic kidney disease (estimated glomerular filtration (eGFR) rate/creatinine clearance <45 mL/min); severe infection or gastrointestinal bleed

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

In this feasibility trial, a digital follow-up treatment strategy with patient self-management app (Urika) and remote monitoring in specialist healthcare for patients with gout will be tested.

The group in the trial

  • To determine the feasibility of a patient self-management application (Urika) in patients with gout.Treatment being tested

    The intended purpose of the app is to support self-management for patients with gout that initiate urate lowering therapy.

    Treatment: "Urika", a self-management application for patients with gout

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The ReMonit Gout Feasibility Study
Publications
Record updated
11 December 2024